发明名称 QUINAZOLINE DERIVATIVES, PROCESS FOR PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
摘要 4-Anilino-quinazoline derivatives of formula (I) and their salts are new. m = 1 or 2; R1 = H, OH, halo, NO2, CF3, CN, 1-3C alkyl, alkoxy, or alkylthio, or NR5R6; R2 = H, OH, halo, MeO, amino, or NO2; R3 = OH, halo, 1-3C alkyl, alkoxy, or alkanoyloxy, CF3, CN, amino, or NO2; X1 = O, CH2, S, SO, SO2, NR7CO, CONR8, SO2NR9, NR10SO2, or NR11; R5, R6 = H or 1-3C alkyl; R7-R11 = H, 1-3C alkyl, or 1-3C alkoxy(2-3C alkyl); R4 = WR12 (linked through a C atom of R12), WR13, (2-5C alkenylene)-R14, (2-5C alkynylene)-R15, W-X2-W-X3-R16, W-X4-COR22, W-X5-R27, W-X6-W-R33, R39, W-R40, W-R43, or W-R44; when X1 = O, S, SO, or SO2, then R4 can also = 1-3C alkoxy 2-4C alkyl; when X1 = O, then R4 can also = 1-4C alkyl; and provided that, when R4 = W-X2-W-X3-R16, then X1 is not CH2; W = 1-5C alkylene; X2, X3 = as X1, but not CH2; X4 = O or NR23; X5 = OCO, or as X1, but not CH2; X6 = as X1, but not CH2; R12, R14, R15 = Het; Het = 5 or 6 membered saturated heterocyclyl, containing 1 or 2 heteroatoms from O, S, N (optionally containing 1 or 2 substituents G); G = oxo, OH, halo, 1-4C alkyl, alkoxy, or hydroxyalkyl, 1-4C alkanoyl, 2-5C alkoxycarbonyl, carbamoyl, or mono- or di- (1-4C alkyl)carbamoyl; R13 = pyrrolidin-1-yl, imidazolidin-1-yl, or thiomorpholinyl (optionally containing 1 or 2 substituents G); R16 = H or 1-3C alkyl; R22 = NR24R25 or OR26; R23-R26 = as R7; R27, R33 = cyclopentyl, cyclohexyl, or Het (all optionally containing 1 or 2 substituents G), or 1-3C alkyl; provided that, when R27 = 1-3C alkyl, then X5 is a group containing S, and X1 is not CH2; R39 = pyrrolidin-3-yl, piperidin-3-yl, or piperidin-4-yl (all optionally containing 1 or 2 substituents G); R40 = piperazin-1-yl (substituted by 1 or more 1-4C alkanoyl or hydroxyalkyl, 2-5C alkoxycarbonyl, or CONR41R42); R41, R42 = H or 1-4C alkyl; R43 = morpholinyl (optionally containing 1 or 2 substituents G); and R44 = morpholinyl (substituted by at least one, and optionally 2, G); provided that when R4 = alkoxyalkyl or alkyl then R1 and/or R2 = NO2 or /- 1 R3 = 1-3C alkanoyloxy.
申请公布号 HU9902850(A2) 申请公布日期 2000.04.28
申请号 HU19990002850 申请日期 1997.09.23
申请人 ZENECA Limited;ZENECA-PHARMA S.A. 发明人 CLAYTON, EDWARD;HENNEQUIN, LAURENT FRANCOIS ANDRE;JOHNSTONE, CRAIG;LOHMANN, JEAN-JACQUES MARCEL;STOKES, ELAINE SOPHIE ELIZABETH;THOMAS, ANDREW PETER
分类号 A61F13/00;A61F13/02;A61F13/15;A61K31/505;A61K31/517;A61K31/5377;A61K31/541;A61P3/10;A61P9/00;A61P9/10;A61P13/12;A61P17/06;A61P19/02;A61P27/02;A61P29/00;A61P35/00;A61P37/00;A61P37/02;A61P43/00;C07D207/00;C07D211/00;C07D239/72;C07D239/93;C07D239/94;C07D309/02;C07D317/08;C07D401/12;C07D403/12;C07D405/12;C07D413/12;C07D417/02;C07D417/12 主分类号 A61F13/00
代理机构 代理人
主权项
地址